Skip to contentC
Cardio Diagnostics Holdings, Inc.
C
CDIOCardio Diagnostics Holdings, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.56K$3.56Kderived−21.2% vs Q4 2024 Net Income-$1.47M-$1.47MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardio Diagnostics Holdings, Inc. · CIK 1870144 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,463,222N/M Operating Cash Flowderived-$1,361,849N/M Free Cash Flowderived-$1,361,849N/M Margins · derivedOperating margin-41159.5%−7551.3 pt vs Q4 2024
Net margin-41219.9%−7547.3 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 13, 2026 · 72 d after period end